Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Polack

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Medicine Reports|April 8, 2011
B-cell-specific elements enhance sustained gene expression mediated by self-replicating extrachromosomal vectorsDominique Zehnpfennig, Helmut Deissler, Axel Polack, et al.
The Journal of General Virology|November 21, 2001
Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switchAlexander Pajic, Axel Polack, Martin S Staege, et al.
Molecular Carcinogenesis|March 1, 2002
The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cellsManfred Hergenhahn, Ubaldo Soto, Annette Weninger, et al.
Cancer Research|January 28, 2004
Moderate hypermutability of a transgenic lacZ reporter gene in Myc-dependent inflammation-induced plasma cell tumors in miceKlaus Felix, Axel Polack, Walter Pretsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transportDoriana Fruci, Grégoire Lauvau, Loredana Saveanu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2002
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cellsMartin S Staege, Steven P Lee, Teresa Frisan, et al.
Nature|September 17, 2010
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaMarina Cavazzana-Calvo, Emmanuel Payen, Olivier Negre, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Medicine Reports|April 8, 2011
B-cell-specific elements enhance sustained gene expression mediated by self-replicating extrachromosomal vectorsDominique Zehnpfennig, Helmut Deissler, Axel Polack, et al.
The Journal of General Virology|November 21, 2001
Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switchAlexander Pajic, Axel Polack, Martin S Staege, et al.
Molecular Carcinogenesis|March 1, 2002
The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cellsManfred Hergenhahn, Ubaldo Soto, Annette Weninger, et al.
Cancer Research|January 28, 2004
Moderate hypermutability of a transgenic lacZ reporter gene in Myc-dependent inflammation-induced plasma cell tumors in miceKlaus Felix, Axel Polack, Walter Pretsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transportDoriana Fruci, Grégoire Lauvau, Loredana Saveanu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2002
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cellsMartin S Staege, Steven P Lee, Teresa Frisan, et al.
Nature|September 17, 2010
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaMarina Cavazzana-Calvo, Emmanuel Payen, Olivier Negre, et al.
Pageof 1